TY - JOUR
T1 - Cobalt protoporphyrin represses osteoclastogenesis through blocking multiple signaling pathways
AU - Yashima, Yuka
AU - Okamoto, Kuniaki
AU - Sakai, Eiko
AU - Iwatake, Mayumi
AU - Fukuma, Yutaka
AU - Nishishita, Kazuhisa
AU - Tsukuba, Takayuki
N1 - Funding Information:
This work was supported in part by Grants-in-Aid for Scientific Research (B) Grant Number 25293383, 15H05298, and for Exploratory Research Grant Number 30264055. (T.T).
Publisher Copyright:
© 2015 Springer Science+Business Media New York.
PY - 2015/8/27
Y1 - 2015/8/27
N2 - Cobalt protoporphyrin (CoPP) is a metallo-protoporphyrin that works as a powerful inducer of heme oxigenase-1 (HO-1) in various tissues and cells. Our recent studies have demonstrated that induction of HO-1 by several reagents inhibited differentiation and activation of osteoclasts (OCLs), which are multinucleated bone resorbing cells. However, the effects of CoPP on osteoclastogenesis remain to be elucidated. In this study, we report that CoPP inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced OCL formation in a dose dependent manner. Importantly, CoPP had little cytotoxicity, but rather enhanced cell proliferation of OCLs. CoPP suppressed the protein levels of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) as well as those of OCLs markers such as Src and cathepsin K, which are transcriptionally regulated by NFATc1 in mature OCLs. Western blot analyses also showed that CoPP abolished RANKL-stimulated phosphorylation of several major signaling pathways such as IκB, Akt, ERK, JNK and p38 MAPKs in OCL precursor cells. Thus, our results show that CoPP represses osteoclastogenesis through blocking multiple signaling pathways.
AB - Cobalt protoporphyrin (CoPP) is a metallo-protoporphyrin that works as a powerful inducer of heme oxigenase-1 (HO-1) in various tissues and cells. Our recent studies have demonstrated that induction of HO-1 by several reagents inhibited differentiation and activation of osteoclasts (OCLs), which are multinucleated bone resorbing cells. However, the effects of CoPP on osteoclastogenesis remain to be elucidated. In this study, we report that CoPP inhibits receptor activator of nuclear factor κB ligand (RANKL)-induced OCL formation in a dose dependent manner. Importantly, CoPP had little cytotoxicity, but rather enhanced cell proliferation of OCLs. CoPP suppressed the protein levels of nuclear factor of activated T cells cytoplasmic-1 (NFATc1) as well as those of OCLs markers such as Src and cathepsin K, which are transcriptionally regulated by NFATc1 in mature OCLs. Western blot analyses also showed that CoPP abolished RANKL-stimulated phosphorylation of several major signaling pathways such as IκB, Akt, ERK, JNK and p38 MAPKs in OCL precursor cells. Thus, our results show that CoPP represses osteoclastogenesis through blocking multiple signaling pathways.
KW - Cobalt protoporphyrin
KW - Hemeoxigenase-1
KW - Osteoclasts
KW - RANKL
UR - http://www.scopus.com/inward/record.url?scp=84933277643&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84933277643&partnerID=8YFLogxK
U2 - 10.1007/s10534-015-9861-9
DO - 10.1007/s10534-015-9861-9
M3 - Article
C2 - 25981584
AN - SCOPUS:84933277643
SN - 0966-0844
VL - 28
SP - 725
EP - 732
JO - BioMetals
JF - BioMetals
IS - 4
ER -